ArthroCare
This article was originally published in The Gray Sheet
Executive Summary
Expanded FDA clearance for the firm's Coblation technology-based radio frequency arthroscopic surgery system includes indications for articular cartilage debridement, ACL/PCL repair, subacromial decompression, meniscectomy and chondroplasty. The system currently is indicated for soft tissue resection, ablation, coagulation and hemostasis in general arthroscopic and orthopedic procedures
You may also be interested in...
ArthroCare RazorVac System Will Drive 10% Arthroscopy Growth In 2002
ArthoCare plans to launch the RazorVac arthroscopy wand for use with its Coblation technology-based radiofrequency arthroscopic surgery system in knee procedures by the first quarter of 2002
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.